Cargando…

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression

Treatment-resistant depression (TRD) is a serious problem in adolescents. Development and optimization of novel interventions for these youth will require a deeper knowledge of the neurobiology of depression. A well-established phenomenon of depression is an attention bias toward negativity and away...

Descripción completa

Detalles Bibliográficos
Autores principales: Thai, Michelle, Başgöze, Zeynep, Klimes-Dougan, Bonnie, Mueller, Bryon A., Fiecas, Mark, Lim, Kelvin O., Albott, C. Sophia, Cullen, Kathryn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461781/
https://www.ncbi.nlm.nih.gov/pubmed/33013493
http://dx.doi.org/10.3389/fpsyt.2020.00820
_version_ 1783576788141604864
author Thai, Michelle
Başgöze, Zeynep
Klimes-Dougan, Bonnie
Mueller, Bryon A.
Fiecas, Mark
Lim, Kelvin O.
Albott, C. Sophia
Cullen, Kathryn R.
author_facet Thai, Michelle
Başgöze, Zeynep
Klimes-Dougan, Bonnie
Mueller, Bryon A.
Fiecas, Mark
Lim, Kelvin O.
Albott, C. Sophia
Cullen, Kathryn R.
author_sort Thai, Michelle
collection PubMed
description Treatment-resistant depression (TRD) is a serious problem in adolescents. Development and optimization of novel interventions for these youth will require a deeper knowledge of the neurobiology of depression. A well-established phenomenon of depression is an attention bias toward negativity and away from positivity that is evidenced behaviorally and neurally, but it is unclear how symptom reduction is related to changes to this bias. Neurobiological research using a treatment probe has promise to help discover the neural changes that accompany symptom improvement. Ketamine has utility for such research because of its known rapid and strong antidepressant effects in the context of TRD. Our previous study of six open-label ketamine infusions in 11 adolescents with TRD showed variable response, ranging from full remission, partial response, non-response, or clinical worsening. In this study, we examined the performance of these participants on Word Face Stroop (WFS) fMRI task where they indicated the valence of affective words superimposed onto either congruent or incongruent emotional faces before and after the ketamine infusions. Participants also completed a clinical assessment (including measurement of depression symptomology and anhedonia/pleasure) before and after the ketamine infusions. Following ketamine treatment, better WFS performance correlated with self-reported decreased depressive symptoms and increased pleasure. Analyses of corticolimbic, corticostriatal and default mode (DMN) networks showed that across networks, decreased activation during all conditions (congruent negative, congruent positive, incongruent negative, and incongruent positive) correlated with decreases in depressive symptoms and with increases in pleasure. These findings suggest that in adolescents with TRD, clinical improvement may require an attenuation of the negativity bias and re-tuning of these three critical neural networks to attenuate DMN and limbic regions activation and allow more efficient recruitment of the reward network. Lower activation across conditions may facilitate shifting across different salient emotional stimuli rather than getting trapped in downward negative spirals.
format Online
Article
Text
id pubmed-7461781
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74617812020-10-01 Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression Thai, Michelle Başgöze, Zeynep Klimes-Dougan, Bonnie Mueller, Bryon A. Fiecas, Mark Lim, Kelvin O. Albott, C. Sophia Cullen, Kathryn R. Front Psychiatry Psychiatry Treatment-resistant depression (TRD) is a serious problem in adolescents. Development and optimization of novel interventions for these youth will require a deeper knowledge of the neurobiology of depression. A well-established phenomenon of depression is an attention bias toward negativity and away from positivity that is evidenced behaviorally and neurally, but it is unclear how symptom reduction is related to changes to this bias. Neurobiological research using a treatment probe has promise to help discover the neural changes that accompany symptom improvement. Ketamine has utility for such research because of its known rapid and strong antidepressant effects in the context of TRD. Our previous study of six open-label ketamine infusions in 11 adolescents with TRD showed variable response, ranging from full remission, partial response, non-response, or clinical worsening. In this study, we examined the performance of these participants on Word Face Stroop (WFS) fMRI task where they indicated the valence of affective words superimposed onto either congruent or incongruent emotional faces before and after the ketamine infusions. Participants also completed a clinical assessment (including measurement of depression symptomology and anhedonia/pleasure) before and after the ketamine infusions. Following ketamine treatment, better WFS performance correlated with self-reported decreased depressive symptoms and increased pleasure. Analyses of corticolimbic, corticostriatal and default mode (DMN) networks showed that across networks, decreased activation during all conditions (congruent negative, congruent positive, incongruent negative, and incongruent positive) correlated with decreases in depressive symptoms and with increases in pleasure. These findings suggest that in adolescents with TRD, clinical improvement may require an attenuation of the negativity bias and re-tuning of these three critical neural networks to attenuate DMN and limbic regions activation and allow more efficient recruitment of the reward network. Lower activation across conditions may facilitate shifting across different salient emotional stimuli rather than getting trapped in downward negative spirals. Frontiers Media S.A. 2020-08-18 /pmc/articles/PMC7461781/ /pubmed/33013493 http://dx.doi.org/10.3389/fpsyt.2020.00820 Text en Copyright © 2020 Thai, Başgöze, Klimes-Dougan, Mueller, Fiecas, Lim, Albott and Cullen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Thai, Michelle
Başgöze, Zeynep
Klimes-Dougan, Bonnie
Mueller, Bryon A.
Fiecas, Mark
Lim, Kelvin O.
Albott, C. Sophia
Cullen, Kathryn R.
Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
title Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
title_full Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
title_fullStr Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
title_full_unstemmed Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
title_short Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
title_sort neural and behavioral correlates of clinical improvement to ketamine in adolescents with treatment resistant depression
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461781/
https://www.ncbi.nlm.nih.gov/pubmed/33013493
http://dx.doi.org/10.3389/fpsyt.2020.00820
work_keys_str_mv AT thaimichelle neuralandbehavioralcorrelatesofclinicalimprovementtoketamineinadolescentswithtreatmentresistantdepression
AT basgozezeynep neuralandbehavioralcorrelatesofclinicalimprovementtoketamineinadolescentswithtreatmentresistantdepression
AT klimesdouganbonnie neuralandbehavioralcorrelatesofclinicalimprovementtoketamineinadolescentswithtreatmentresistantdepression
AT muellerbryona neuralandbehavioralcorrelatesofclinicalimprovementtoketamineinadolescentswithtreatmentresistantdepression
AT fiecasmark neuralandbehavioralcorrelatesofclinicalimprovementtoketamineinadolescentswithtreatmentresistantdepression
AT limkelvino neuralandbehavioralcorrelatesofclinicalimprovementtoketamineinadolescentswithtreatmentresistantdepression
AT albottcsophia neuralandbehavioralcorrelatesofclinicalimprovementtoketamineinadolescentswithtreatmentresistantdepression
AT cullenkathrynr neuralandbehavioralcorrelatesofclinicalimprovementtoketamineinadolescentswithtreatmentresistantdepression